Literature DB >> 10932066

Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study.

A Linneberg1, N H Nielsen, F Madsen, L Frølund, A Dirksen, T Jørgensen.   

Abstract

BACKGROUND: There is evidence that the prevalence of respiratory allergy has increased in children in many countries. However, this evidence is largely based on questionnaire data, and little is known about similar trends in adults.
OBJECTIVE: We investigated whether the prevalence of specific IgE to aeroallergens had increased in an adult general population over an 8-year period.
METHODS: Two cross-sectional surveys were carried out in 1990 and 1998. A mailed screening questionnaire on respiratory symptoms sent to random samples of 15- to 41-year-old subjects living in Copenhagen (Denmark) preceded both surveys. Random samples of responders were invited to a health examination, including assessment of specific IgE to 6 common aeroallergens. Totals of 312 (74.6% of the invited subjects) and 482 (53.4% of the invited subjects) subjects were examined in 1990 and 1998, respectively. Analyses of serum samples from both surveys were performed in 1999.
RESULTS: The prevalence of specific IgE to at least one allergen increased significantly from 1990 to 1998 (26.5% vs 33.9%; odds ratio adjusted for sex, age, and season of examination, 1.63; 95% confidence interval, 1.15-2.32; P = .006). This increase remained unexplained after adjustment for changes in questionnaire variables on lifestyle and home environment. The clinical significance of this increase was underlined by a corresponding increase in the prevalence of allergic rhinitis symptoms associated with specific IgE positivity.
CONCLUSION: We found that the prevalence of specific IgE positivity to aeroallergens increased in an adult Danish general population from 1990 and 1998.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932066     DOI: 10.1067/mai.2000.108312

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  24 in total

1.  The changing prevalence of asthma?

Authors:  P Burney
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 2.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Changes in atopy over a quarter of a century, based on cross sectional data at three time periods.

Authors:  Malcolm Law; Joan K Morris; Nicholas Wald; Christina Luczynska; Peter Burney
Journal:  BMJ       Date:  2005-04-15

Review 4.  Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

Authors:  Camille Jacqueline; Olivera J Finn
Journal:  Semin Immunol       Date:  2020-04-06       Impact factor: 11.130

5.  Allergic sensitization and microbial load--a comparison between Finland and Russian Karelia.

Authors:  T Seiskari; A Kondrashova; H Viskari; M Kaila; A-M Haapala; J Aittoniemi; M Virta; M Hurme; R Uibo; M Knip; H Hyöty
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

6.  Survey of clinical allergy services provided by clinical immunologists in the UK.

Authors:  T M El-Shanawany; H Arnold; E Carne; S A Misbah; W Egner; T B Wallington; R Herriot; P E Williams
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

7.  Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study.

Authors:  Anna Asarnoj; Carl Hamsten; Konrad Wadén; Christian Lupinek; Niklas Andersson; Inger Kull; Mirela Curin; Josep Anto; Jean Bousquet; Rudolf Valenta; Magnus Wickman; Marianne van Hage
Journal:  J Allergy Clin Immunol       Date:  2015-12-10       Impact factor: 10.793

Review 8.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

9.  Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®.

Authors:  Moisés Calderón; Tove Brandt
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

Review 10.  Aeroallergens, allergic disease, and climate change: impacts and adaptation.

Authors:  Colleen E Reid; Janet L Gamble
Journal:  Ecohealth       Date:  2009-09       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.